Anson Funds Management’s Psyence Biomedical Warrant PBMWW Stock Holding History

Anson Funds Management’s Portfolio PBMWW Stock Details PBMWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-12,500	Closed	-$1.25K	–	234
2024 Q3	$1.25K	Hold	12,500	–	–	﹤0.01%	157
2024 Q2	$3.75K	Hold	12,500	–	–	﹤0.01%	154
2024 Q1	$14.3K	Buy	+12,500	New	+$779	﹤0.01%	147

Other funds holding PBMWW

Harraden Circle Investments New York $499M AUM 24.03% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $4.21B AUM 35.27% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Calamos Advisors

Calamos Advisors Naperville, Illinois $25.9B AUM 21.78% 1-Year Est. Return

Cantor Fitzgerald New York $2.76B AUM 29.01% 1-Year Est. Return

Saba Capital Management New York $3.12B AUM 13% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.36B AUM 24.94% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

LMR Partners London, United Kingdom $10.9B AUM 60.68% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $574M AUM 6.51% 1-Year Est. Return